...
首页> 外文期刊>The Journal of Physiology >Cardioprotection in ischaemia-reperfusion injury: novel mechanisms and clinical translation
【24h】

Cardioprotection in ischaemia-reperfusion injury: novel mechanisms and clinical translation

机译:缺血再灌注损伤中的心脏保护作用:新机制和临床翻译

获取原文
获取原文并翻译 | 示例
           

摘要

In recent decades, robust successes have been achieved in conquering the acutely lethal manifestations of heart disease. Nevertheless, the prevalence of heart disease, especially heart failure, continues to rise. Among the precipitating aetiologies, ischaemic disease is a leading cause of heart failure. In the context of ischaemia, the myocardium is deprived of oxygen and nutrients, which elicits a cascade of events that provokes cell death. This ischaemic insult is typically coupled with reperfusion, either spontaneous or therapeutically imposed, wherein blood supply is restored to the previously ischaemic tissue. While this intervention limits ischaemic injury, it triggers a new cascade of events that is also harmful, viz. reperfusion injury. In recent years, novel insights have emerged regarding mechanisms of ischaemia-reperfusion injury, and some hold promise as targets of therapeutic relevance. Here, we review a select number of these pathways, focusing on recent discoveries and highlighting prospects for therapeutic manipulation for clinical benefit.
机译:在最近几十年中,在克服心脏病的致命性表现方面取得了巨大的成功。然而,心脏病,尤其是心力衰竭的患病率持续上升。在促发性病因中,缺血性疾病是心力衰竭的主要原因。在局部缺血的情况下,心肌被剥夺了氧气和营养,这引发了一系列引发细胞死亡的事件。这种缺血性损伤通常与自发性或治疗性再灌注相结合,其中血液供应恢复到先前的缺血组织。虽然这种干预限制了缺血性损伤,但它触发了一系列新的事件,这也是有害的,即。再灌注损伤。近年来,关于缺血-再灌注损伤的机制出现了新的见解,并且有希望成为治疗相关性的靶标。在这里,我们回顾了这些途径中的一部分,重点是最近的发现,并着重介绍了为临床受益而进行治疗性操作的前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号